Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in randomized trial participants and nonenrolled eligible patients: A secondary analysis of a randomized clinical trial

Clemens Von Birgelen*, Liefke C. Van Der Heijden, Mounir Welson Zakhary Basalus, Marlies M. Kok, Hanim Sen, Hans W. Louwerenburg, Gert K. van Houwelingen, Martin G. Stoel, Frits H.A.F. de Man, Gerard C.M. Linssen, Kenneth Tandjung, Carine J.M. Doggen, Job van der Palen, Marije M. Löwik

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Fingerprint Dive into the research topics of 'Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in randomized trial participants and nonenrolled eligible patients: A secondary analysis of a randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences